Brief: Ibio And Astralbio Provide Update On Myostatin Program For Obesity

iBio

10/10/2024 13:08

Oct 10 (Reuters) - Ibio Inc  IBIO.A :
    * IBIO AND ASTRALBIO PROVIDE UPDATE ON MYOSTATIN PROGRAM FOR
OBESITY
    * IBIO INC - PLANS NON-CGMP IN VIVO STUDIES WITH EARLY 2025
READOUTS
    * IBIO INC - AIMS TO FILE IND APPLICATION FOR MYOSTATIN
PROGRAM BY
END OF 2025
    * IBIO INC - HAS EXCLUSIVE OPTION TO LICENSE THREE
CARDIOMETABOLIC
TARGETS FROM ASTRALBIO

Source text for Eikon:  ID:nGNX3DRgNR 
Further company coverage:  IBIO.A 

 ((Reuters.Briefs@thomsonreuters.com;))